Year: 2007
Type: article
Abstract: We published an evidence-based guideline for the diagnosis, investigation and management of polycythaemia/erythrocytosis (McMullin et al, 2005). It has subsequently been reported that the mutation JAK2V617F is present in approximately 95% of patients with polycythaemia vera (PV) especially if a polymerase chain reaction-based detection method is used (Baxter et al, 2005; James et al, 2005; Kralovics et al, 2005; Levine et al, 2005). Moreover different JAK2 mutations (affecting exon 12) are found in patients with PV who lack the V617F mutation (Scott et al, 2007). The presence of these abnormalities has implications for the diagnosis and therefore investigation of polycythaemia. JAK2 mutations (both V617F and exon 12 mutations) can be detected in the peripheral blood using one of several sensitive molecular methods and are not associated with relative or secondary erythrocytosis. We therefore propose that the diagnostic criteria for PV should be adapted as shown in Table I, as suggested by Campbell and Green (2006). This simplifies the diagnosis and the need for investigation in those who are JAK2 mutation positive. In the JAK2 negative group, the platelet count threshold is raised from 400 × 109/l to 450 × 109/l, which is in keeping with the upper limit of the normal range in most laboratories. These diagnostic criteria will alter the number and sequence in which investigations need to be carried out. Start with a thorough history and examination, to identify most patients with a secondary cause and arrange confirmatory investigations. Then stage 1 initial screening tests will identify those with JAK2-positive clonal disease in whom there is no need to proceed further with further investigations: History and examination Full blood count/film JAK2 mutation Serum ferritin Renal and liver function tests If the initial screening tests are negative for a JAK2 mutation and there is no obvious secondary cause then further investigations are indicated. A red cell mass is required first and if an absolute erythrocytosis is confirmed then the following tests are appropriate. Red cell mass Arterial oxygen saturation Abdominal ultrasound Serum erythropoietin level Bone marrow aspirate and trephine Cytogenetic analysis Erythroid burst-forming unit (BFU-E) culture For those patients who do not fulfil either set of criteria and who have erythrocytosis there are a number of specialised tests that may need to be considered. Some of these are listed below. Arterial oxygen dissociation Sleep study Lung function studies Gene mutations EPOR, VHL, EGLN1 (also known as PHD2)
Source: British Journal of Haematology
Institution: Belfast City Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2068302080
